Seaport Global Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
Seaport Global Advisors's AMED Position: Q3 2023 in Review
Seaport Global Advisors sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,535 shares — an estimated $232K sold.
Seaport Global Advisors first reported a position in AMED in Q2 2022 and held it in 5 quarters. The position peaked at $232K in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- Seaport Global Advisors reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- Seaport Global Advisors sold 2,535 Amedisys shares in Q3 2023, an estimated $232K.
- Seaport Global Advisors first reported a position in Amedisys in Q2 2022 and held it in 5 quarters.
- Seaport Global Advisors's Amedisys position peaked at $232K in Q2 2023.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on Seaport Global Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.